Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

10,000 people tested: Cambodia's massive disease hunt begins

NCT ID NCT07358910

Knowledge-focused Sponsor: Institut Pasteur du Cambodge Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test 10,000 people in Cambodia for 57 different infectious diseases, including dengue, flu, and malaria. Researchers want to understand how these diseases spread and who is at risk. The goal is to give local health authorities the information they need to create better prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide clear data on which diseases are most common and how they spread, helping local health officials design better prevention and control programs.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly help participants. Results depend on accurate testing and may not apply to other countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises approximately 10,000 participants aged 2 to 75 years, drawn from 4,160 households across Cambodia's 25 provinces. Households will be randomly selected from 104 villages to ensure a nationally representative sample that reflects the country's diverse geographic and demographic characteristics. Participants will provide detailed socio-demographic information, enabling post-stratification weighted analysis of the sample's structure by sex, age, and geographic area to facilitate the extrapolation of findings to the entire population, ensuring that the study's conclusions are broadly applicable.

Ages

2 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Residency in the village for more than 6 months; * Age between 2 and 75 years old at the time of inclusion; * For adults: provision of written consent; * For children aged 2-17 years: written parental consent form, verbal assent from children aged 13-17 years; Exclusion Criteria: * Unable to understand or consent; * Under guardianship or deprived of liberty; * Medical conditions that impede survey participation; * Refusal to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenovirus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenoviridae infectious disease amoebiasis due to Entamoeba histolytica Arenaviridae infectious disease ascariasis brucellosis Bunyaviridae infectious disease Caliciviridae infectious disease chickenpox chikungunya chlamydia infectious disease chlamydia trachomatis infectious disease cholera clonorchiasis cytomegalovirus infection dengue disease diphtheria enterovirus infectious disease Epstein-Barr virus infection filarial elephantiasis filariasis giardiasis hantavirus infectious disease henipavirus infectious disease hepatitis A virus infection hepatitis E virus infection human papilloma virus infection infectious disease influenza Japanese encephalitis Legionnaires' disease leishmaniasis leptospirosis malaria measles melioidosis meningitis mumps infectious disease Mycoplasma Infections Mycoplasmoides infection Neglected Diseases Nipah virus disease norovirus infectious disease opisthorchiasis Oropouche fever Parvoviridae infectious disease pertussis Q fever respiratory syncytial virus infectious disease Rift valley fever Rotavirus infection rubella schistosomiasis Severe Fever with Thrombocytopenia Syndrome streptococcal pneumonia strongyloidiasis tetanus tick-borne encephalitis toxoplasmosis trichuriasis typhoid fever Vaccine-Preventable Diseases vector-borne disease viral hemorrhagic fever yellow fever Zika virus infectious disease Zoonoses

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenovirus Arenavirus infections Ascaris lumbricoides Brucellosis Chikungunya Chlamydia Clonorchis sinensis Cytomegalovirus Dengue Diphteria Entamoeba histolytica Enterovirus Epstein-Barr virus Giardiasis Hantavirus infections Hepatitis A Hepatitis E Human papilloma virus (HPV) Influenza A and B Japanese encephalitis Legionella pneumophila pneumonia Leishmaniasis Leptospirosis Lymphatic filariasis Malaria Mayaro fever Measles Melioidosis Meningitis Mumps Mycoplasma Nipah virus infection Norovirus infections Opisthorchis viverrini Oropouche fever Parvovirus Pertussis Q fever Respiratory syncytial virus (RSV) Rhinovirus Rift valley fever Rotavirus disease Rubella Salmonella typhi Schistosomiasis Severe fever with thrombocytopenia syndrome Streptococcus pneumoniae Strongyloides stercoralis infection Tetanus Tick-borne encephalitis (TBE) Toxoplasma gondii Trichuris trichiura Usutu virus infection Varicella Vibrio cholerae West nile virus Yellow fever Zika virus infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut Pasteur du Cambodge

    RECRUITING

    Phnom Penh, Phnom Penh, 12201, Cambodia

More trials for these conditions

Other studies related to the condition(s) this trial covers.